Clinical trials reveal promising alternatives to highly toxic tuberculosis drug
The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile compared to linezolid, with…
The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile compared to linezolid, with…
Recent research suggests that the emergence of tuberculosis infection in human populations dates back tens of thousands of years earlier…